| Sign In to gain access to subscriptions and/or personal tools. |
Poor prognosis of end-stage renal disease in systemic lupus erythematosus: a cohort of Chinese patientsDivision of Nephrology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, National Yang-Ming University, School of Medicine, Taipei, Taiwan, Institute of Clinical Medicine, National Cheng Kung University Medical College, Tainan, Taiwan
Division of Nephrology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, National Yang-Ming University, School of Medicine, Taipei, Taiwan
Division of Nephrology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
National Yang-Ming University, School of Medicine, Taipei, Taiwan, Department of Pediatrics, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
Division of Nephrology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, National Yang-Ming University, School of Medicine, Taipei, Taiwan, kjchou{at}isca.vghks.gov.tw
Division of Nephrology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, National Yang-Ming University, School of Medicine, Taipei, Taiwan We studied the clinical course of 26 systemic lupus erythematosus(SLE) patients who started regular dialysis at our hospital and whose stay exceeded a three-month duration in order to investigate the long-term prognosis in a Chinese cohort. Clinical and serological activities of lupus before and after dialysis were analysed. To compare the long-term survival rate, controls were set using 78 age-matched end-stage renal disease (ESRD) patients who did not have SLE or diabetes mellitus and entered the chronic dialysis program at a similar period with SLE dialysis patients. There was a significant decrease in clinical lupus activity after starting regular dialysis (P < 0.05); however, the serologicalactivity remained the same. The five-and ten-yearsurvivalrates were significantly lower in the SLE patients (73 and 38% in the SLE group versus 95 and 88% in the non-SLE group, P < 0.05). SLE patients had a 4.3-times higher risk of death than non-SLE patients (P < 0.05, 95% confidence interval,1.2-15.2). Also, the deceased SLE patients had persistent lower serum levels of complement 3. SLE patients with ESRD remain clinically quiescent despite persistent serological abnormalities and have a worse prognosis than other uremia patients in the Chinese population.
Key Words: dialysis end-stage renal disease lupus nephritis mortality systemic lupus erythematosus
Lupus, Vol. 12, No. 11,
827-832 (2003) This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||

